These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9089331)

  • 21. Pharmacological characterisation of the enantiomers of BM-5, a muscarinic partial agonist with opposed enantioselectivity between affinity and efficacy.
    Sundquist S; Modiri AR; Nilsson BM; Hacksell U; Gillberg PG; Nilvebrant L
    Pharmacol Toxicol; 2000 Jan; 86(1):44-50. PubMed ID: 10720106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists.
    Messer WS; Abuh YF; Liu Y; Periyasamy S; Ngur DO; Edgar MA; El-Assadi AA; Sbeih S; Dunbar PG; Roknich S; Rho T; Fang Z; Ojo B; Zhang H; Huzl JJ; Nagy PI
    J Med Chem; 1997 Apr; 40(8):1230-46. PubMed ID: 9111297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple method for estimation of agonist activity at receptor subtypes: comparison of native and cloned M3 muscarinic receptors in guinea pig ileum and transfected cells.
    Ehlert FJ; Griffin MT; Sawyer GW; Bailon R
    J Pharmacol Exp Ther; 1999 May; 289(2):981-92. PubMed ID: 10215678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of release-inhibiting muscarinic autoreceptors in heart atria and urinary bladder: a study with M(2)- and M(4)-receptor-deficient mice.
    Zhou H; Meyer A; Starke K; Gomeza J; Wess J; Trendelenburg AU
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):112-22. PubMed ID: 11819029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and pharmacological investigation of the enantiomers of muscarone and allomuscarone.
    De Amici M; Dallanoce C; De Micheli C; Grana E; Barbieri A; Ladinsky H; Schiavi G; Zonta F
    J Med Chem; 1992 May; 35(10):1915-20. PubMed ID: 1588567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
    Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
    J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and structure-activity relationship studies in a series of 2-substituted 1,3-dioxolanes modified at the cationic head.
    Angeli P; Brasili L; Cingolani ML; Marucci G; Piergentili A; Pigini M; Quaglia W
    Bioorg Med Chem; 1997 Apr; 5(4):731-7. PubMed ID: 9158872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Function of M3 muscarinic receptors in the rat urinary bladder following partial outlet obstruction.
    Krichevsky VP; Pagala MK; Vaydovsky I; Damer V; Wise GJ
    J Urol; 1999 May; 161(5):1644-50. PubMed ID: 10210432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analgesic, antimuscarinic activity and enantioselectivity of the four isomers of 3-quinuclidinyl tropate as compared with the enantiomers of hyoscyamine.
    Dei S; Bellucci C; Gualtieri F; Romanelli MN; Scapecchi S; Teodori E; Bartolini A; Ghelardini C
    Farmaco; 1995 May; 50(5):303-9. PubMed ID: 7626164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscarinic receptor function, density and G-protein coupling in the overactive diabetic rat bladder.
    Stevens LA; Sellers DJ; McKay NG; Chapple CR; Chess-Williams R
    Auton Autacoid Pharmacol; 2006 Jul; 26(3):303-9. PubMed ID: 16879496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bis(ammonio)alkane-type agonists of muscarinic acetylcholine receptors: synthesis, in vitro functional characterization, and in vivo evaluation of their analgesic activity.
    Matera C; Flammini L; Quadri M; Vivo V; Ballabeni V; Holzgrabe U; Mohr K; De Amici M; Barocelli E; Bertoni S; Dallanoce C
    Eur J Med Chem; 2014 Mar; 75():222-32. PubMed ID: 24534538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
    Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
    Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacological characterization of O-alkynyloximes of tropinone and N-methylpiperidinone as muscarinic agonists.
    Xu R; Sim MK; Go ML
    J Med Chem; 1998 Aug; 41(17):3220-31. PubMed ID: 9703467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The M2 muscarinic receptor mediates contraction through indirect mechanisms in mouse urinary bladder.
    Ehlert FJ; Griffin MT; Abe DM; Vo TH; Taketo MM; Manabe T; Matsui M
    J Pharmacol Exp Ther; 2005 Apr; 313(1):368-78. PubMed ID: 15608083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.
    Scapecchi S; Matucci R; Bellucci C; Buccioni M; Dei S; Guandalini L; Martelli C; Manetti D; Martini E; Marucci G; Nesi M; Romanelli MN; Teodori E; Gualtieri F
    J Med Chem; 2006 Mar; 49(6):1925-31. PubMed ID: 16539379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholinergic activation of phasic activity in the isolated bladder: possible evidence for M3- and M2-dependent components of a motor/sensory system.
    Finney SM; Stewart LH; Gillespie JI
    BJU Int; 2007 Sep; 100(3):668-78. PubMed ID: 17627783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog.
    Ji F; Huang F; Juhasz A; Wu W; Bodor N
    Pharmazie; 2000 Mar; 55(3):187-91. PubMed ID: 10756538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
    Romanelli MN; Gualtieri F; Valle G; Brasili L; Angeli P
    J Med Chem; 1988 Sep; 31(9):1703-8. PubMed ID: 3411599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.
    Freedman SB; Dawson GR; Iversen LL; Baker R; Hargreaves RJ
    Life Sci; 1993; 52(5-6):489-95. PubMed ID: 8441329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.